Kovitz Investment Group Partners
PROF icon

Kovitz Investment Group Partners’s Profound Medical PROF Stock Holding History

Kovitz Investment Group Partners’s Portfolio PROF Stock Details PROF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-16,722
Closed -$81.7K – 1104
2025
Q3 		$81.7K Hold
16,722
– – ﹤0.01% 1377
2025
Q2 		$98.7K Buy
+16,722
New +$88.4K ﹤0.01% 1326

Other funds holding PROF

Fidelity International
Fidelity International Hamilton, Bermuda $144B AUM 22.91% 1-Year Est. Return
Gagnon Securities
Gagnon Securities New York $577M AUM 61.61% 1-Year Est. Return
Rosalind Advisors
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Royce & Associates
Royce & Associates New York $11B AUM 39.4% 1-Year Est. Return
TIM
Timelo Investment Management Aurora, Ontario, Canada $349M AUM 28.06% 1-Year Est. Return
Letko, Brosseau & Associates
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.9B AUM 29.83% 1-Year Est. Return
GA
Gagnon Advisors New York $182M AUM 52.04% 1-Year Est. Return
Z3 Capital Partners
Z3 Capital Partners Richmond, Virginia $482M AUM 40.01% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return

Kovitz Investment Group Partners's PROF Position: Q4 2025 in Review

Kovitz Investment Group Partners sold out of Profound Medical (PROF) in Q4 2025, closing a stake of 16,722 shares — an estimated $81.7K sold.

Kovitz Investment Group Partners first reported a position in PROF in Q2 2025 and held it in 2 quarters. The position peaked at $98.7K in Q2 2025. 63 funds tracked by Wall St. Rank hold PROF as of Q4 2025.

  • Kovitz Investment Group Partners reported no remaining Profound Medical position as of Q4 2025 after selling out during the quarter.
  • Kovitz Investment Group Partners sold 16,722 Profound Medical shares in Q4 2025, an estimated $81.7K.
  • Kovitz Investment Group Partners first reported a position in Profound Medical in Q2 2025 and held it in 2 quarters.
  • Kovitz Investment Group Partners's Profound Medical position peaked at $98.7K in Q2 2025.
  • 63 funds tracked by Wall St. Rank held Profound Medical as of Q4 2025.

Based on Kovitz Investment Group Partners's 13F filing for Q4 2025, filed 20 Feb 2026.